4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-25-007706
EVP & Chief Technology Officer sold 14,168 shares at $9.45 ($133,936)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HANLY ANN M. EVP & Chief Technology Officer | 2025-02-24 | Sale 10b5-1 | −14,168 | $9.45 | $133,936 | 117,901 | D |
| Open-market sales · 14,168 sh · avg $9.45 · $133,936 | |||||||
Loading xslF345X05/wk-form4_1740516204.xml…